Singapore - Import of Heparin for Therapeutic Use
Since 2014, Singapore Import of Heparin for Therapeutic Use decreased by 3.1% year on year. In 2019, the country was number 3 comparing other countries in Import of Heparin for Therapeutic Use with $365,926,239.55. Singapore is overtaken by United States, which was number 2 at $422,842,642.5 and is followed by Germany at $199,233,065.08. France topped the ranking with $960,128,653.6 in 2019, that is -6.6% compared to 2018. Belize witnessed the best average annual growth at +183.7% per year, while Mauritania witnessed the worst performance at -81.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 365,926,239.55 |
| 2018 | 398,046,560.00 |
| 2017 | 260,808,592.00 |
| 2016 | 309,253,728.00 |
| 2015 | 408,462,976.00 |
Download all data from 1989 to 2019
How does Singapore rank in Import of Heparin for Therapeutic Use?
| # | 152 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
France
|
960,128,653.60 | 2019 | -6.6 % | -5.3 % | View data |
| 2 |
#2
United States
|
422,842,642.50 | 2019 | +0.9 % | +2.3 % | View data |
| 3 |
#3
Singapore
|
365,926,239.55 | 2019 | -8.1 % | -3.1 % | View data |
| 4 |
#4
Germany
|
199,233,065.08 | 2019 | -6.3 % | +0.2 % | View data |
| 5 |
#5
Hungary
|
192,570,738.26 | 2019 | -4.4 % | +2.3 % | View data |